2ND MALIGNANCY FOLLOWING TREATMENT OF ACUTE LYMPHOBLASTIC-LEUKEMIA INCHILDREN

Citation
M. Kubota et al., 2ND MALIGNANCY FOLLOWING TREATMENT OF ACUTE LYMPHOBLASTIC-LEUKEMIA INCHILDREN, International journal of hematology, 67(4), 1998, pp. 397-401
Citations number
21
Categorie Soggetti
Hematology
ISSN journal
09255710
Volume
67
Issue
4
Year of publication
1998
Pages
397 - 401
Database
ISI
SICI code
0925-5710(1998)67:4<397:2MFTOA>2.0.ZU;2-F
Abstract
Second malignancy is one of the serious late effects among long-term s urvivors of acute lymphoblastic leukemia (ALL) in children. Of 83 newl y diagnosed pediatric ALL patients at our hospital between January 198 0 and December 1995, four patients were found to have second malignanc ies. These included MDS/AML after B-ALL, rhabdomyosarcoma after early pre-B ALL, ependymoma after B-ALL, and astrocytoma after early pre-B A LL. The mean duration from initial ALL, to second malignancy was 5.2 y ears. The possible causes of second malignancy in these patients are d iscussed in this report, along with a review of recent literature. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.